{"date":"2025-10-02","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4190-2025-10-02-1900-18rydc7","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-10-02","time":"19:00:21","subject":"公告本公司修訂「中華民國境內第三次無擔保轉換公司債發行及轉換辦法」業經金融監督管理委員會核准","clause":"第51款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-10-02 19:00，「公告本公司修訂「中華民國境內第三次無擔保轉換公司債發行及轉換辦法」業經金融監督管理委員會核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-10-02-1841-j925az","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"18:41:52","subject":"本公司經櫃買中心同意，自114年10月3日起恢復交易","clause":"第40款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-10-02 18:41，「本公司經櫃買中心同意，自114年10月3日起恢復交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-10-02-1750-1bkm0mx","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"17:50:24","subject":"公告本公司代理發言人異動","clause":"第8款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-10-02 17:50，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-10-02-1719-l4hy3r","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"17:19:53","subject":"公告本公司經董事會通過財務主管暨會計主管異動案","clause":"第8款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-10-02 17:19，「公告本公司經董事會通過財務主管暨會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-10-02-1709-1oegxho","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"17:09:17","subject":"公告本公司董事會授權董事長簽訂「無拘束力之投資架構協議」","clause":"第53款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-10-02 17:09，「公告本公司董事會授權董事長簽訂「無拘束力之投資架構協議」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-10-02-1628-ac89kl","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-10-02","time":"16:28:16","subject":"公告本公司申請股票上櫃轉上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-10-02 16:28，「公告本公司申請股票上櫃轉上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-10-02-1624-1518zmd","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-10-02","time":"16:24:26","subject":"公告本公司董事長訂定現金增資認股基準日等相關事宜","clause":"第9款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-10-02 16:24，「公告本公司董事長訂定現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-10-02-1548-1ladvcd","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-10-02","time":"15:48:50","subject":"補充公告本公司中正路辦公室暨展示中心火災事件說明","clause":"第21款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-10-02 15:48，「補充公告本公司中正路辦公室暨展示中心火災事件說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-10-02-1548-gi3647","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-10-02","time":"15:48:27","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-10-02 15:48，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-10-02-1540-154cqlb","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"15:40:35","subject":"本公司董事會決議通過股份轉換案與簽署股份轉換契約","clause":"第11款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-10-02 15:40，「本公司董事會決議通過股份轉換案與簽署股份轉換契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-10-02-1540-1jv40kx","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"15:40:11","subject":"本公司董事會決議通過與聖展生技股份有限公司股份轉換案，擬發行新股","clause":"第11款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-10-02 15:40，「本公司董事會決議通過與聖展生技股份有限公司股份轉換案，擬發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-10-02-1539-1lud6w4","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"15:39:45","subject":"公告本公司召開重大訊息記者會新聞稿內容","clause":"第53款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-10-02 15:39，「公告本公司召開重大訊息記者會新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-10-02-1538-yclg0e","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"15:38:18","subject":"公告本公司因會計師事務所內部輪調更換會計師","clause":"第7款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-10-02 15:38，「公告本公司因會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-10-02-1534-3bed5x","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"15:34:18","subject":"公告本公司財務主管暨會計主管異動","clause":"第8款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-10-02 15:34，「公告本公司財務主管暨會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-10-02-1505-1sy92jc","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-10-02","time":"15:05:56","subject":"更正本公司114年9月營收公告中本月營業收入淨額及本年累計營業收入淨額","clause":"第44款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-10-02 15:05，「更正本公司114年9月營收公告中本月營業收入淨額及本年累計營業收入淨額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-10-02-1430-1mx868u","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-10-02","time":"14:30:29","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-10-02 14:30，「代重要子公司鼎晉生技股份有限公司公告董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}